Skip to main content
SpringerLink
Log in

Bronchopulmonary Dysplasia and Cerebral Palsy

  • Living reference work entry
  • First Online:
Cerebral Palsy

  • 316 Accesses

Abstract

Advances in perinatal care have dramatically improved the outcome of preterm infants over the last few decades. Incidence of Bronchopulmonary Disease (BPD) has remained largely unchanged if not slightly increased over this time period, likely due to the increased survival of extremely preterm infants. BPD is a multifactorial disorder and infants frequently undergo treatment with various pharmacological agents, many of which lack efficacy in studies to date. BPD is an independent risk factor for neurodevelopmental delay and cerebral palsy (CP) in children. Therefore, the presence of CP needs to be considered when treating patients with BPD.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Similar content being viewed by others

References

  • Abman SH, Collaco JM, Shepherd EG et al (2017) Interdisciplinary care of children with severe bronchopulmonary dysplasia. J Pediatr 181:12–28e1

    Article  Google Scholar 

  • Advisory Committee on Immunization Practices (2017) The recommended immunization schedule for children and adolescents aged 18 years or younger. cdc.gov.

    Google Scholar 

  • Barrington KJ (2001) The adverse neuro-developmental effects of postnatal steroids in the preterm infant: a systematic review of RCTs. BMC Pediatr 1:1. Meta-analysis

    Article  CAS  Google Scholar 

  • Bashir RA, Bhandari V, Vayalthrikkovil S et al (2016) Chorioamnionitis at birth does not increase the risk of neurodevelopmental disability in premature infants with bronchopulmonary dysplasia. Acta Paediatr 105:e506–e512

    Article  CAS  Google Scholar 

  • Bhandari A, McGrath-Morrow S (2013) Long-term pulmonary outcomes of patients with bronchopulmonary dysplasia. Semin Perinatol 37:132–137

    Article  Google Scholar 

  • Coalson JJ (2003) Pathology of new bronchopulmonary dysplasia. Semin Neonatol 8(1):73–81

    Article  Google Scholar 

  • Committee on infectious disease and bronchiolitis guideline committee AAP (2014) Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection. Pediatrics 134(2):415–420

    Article  Google Scholar 

  • Donn SM (2017) Bronchopulmonary dysplasia: myths of pharmacologic management. Semin Fetal Neonatal Med 22:354–358

    Article  Google Scholar 

  • Doyle LW, Anderson PJ (2009) Long term outcomes of bronchopulmonary dysplasia. Semin Fetal Neonatal Med 14(6):391–395

    Article  Google Scholar 

  • Doyle LW, Cheong JL, Ehrenkranz RA et al (2017) Late (> 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants. Cochrane Database Syst Rev 10:CD001145-4

    Google Scholar 

  • Fanaroff AA, Stoll BJ, Wright LL, NICHD Neonatal Research Network et al (2007) Trends in neonatal morbidity and mortality for very low birthweight infants. Am J Obstet Gynecol 196:147e1–147e8

    Article  Google Scholar 

  • Fok TF (2009) Adjunctive pharmacotherapy in neonates with respiratory failure. Semin Fetal Neonatal Med 14(1):49–55

    Article  Google Scholar 

  • Fortuna M, Carraro S, Temporin E et al (2016) Mid-childhood lung function in A Cohort of children with “New Bronchopulmonary Dysplasia”. Pediatr Pulmonol 51:1057–1064

    Article  Google Scholar 

  • Gibson AM, Doyle LW (2014) Respiratory outcomes for the tiniest or most immature infants. Semin Fetal Neonatal Med 19:105–111

    Article  Google Scholar 

  • Isayama T, Lee SK, Yang J et al (2017) Revisiting the definition of bronchopulmonary dysplasia effect of changing panoply of respiratory support for preterm neonates. JAMA Pediatr 171(3):271–279

    Article  Google Scholar 

  • Jobe AH, Bancalari E (2001) Bronchopulmonary dysplasia. Am J Respir Crit Care Med 163(7):1723–1729

    Article  CAS  Google Scholar 

  • Malleske DT, Malleske DL, Chorna O, Maitre NL (2017) Pulmonary sequelae and functional limitations in children and adults with bronchopulmonary dysplasia. Paediatr Resp Rev. https://doi.org/10.1016/j.prrv.2017.07.002

    Article  Google Scholar 

  • Manja V, Saugstad OD, Lakshminrusimha S (2017) Oxygen saturation targets in preterm infants and outcomes at 18–24 months: a systematic review. Pediatrics 139(1):e20161609

    Article  Google Scholar 

  • Moon NM, Mohay HA, Gray PH (2007) Developmental patterns from 1 to 4 years of extremely preterm infants who required home oxygen therapy. Early Hum Dev 83:209–216

    Article  Google Scholar 

  • Northway WH Jr, Rosan RC, Porter DY (1967) Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med 276(7):357–368

    Article  Google Scholar 

  • Prais D, Kaplan E, Klinger G et al (2016) Short- and long-term pulmonary outcome of palivizumab in children born extremely prematurely. Chest 149(3):801–808

    Article  Google Scholar 

  • Roberts D, Brown J, Medley N et al (2006) Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev (2)

    Google Scholar 

  • Schmidt B, Roberts RS, Davis P (2006) Caffeine therapy for apnea of prematurity. N Engl J Med 354:2112–2121

    Article  CAS  Google Scholar 

  • Schmidt B, Roberts RS, Davis P (2007) Long-term effects of caffeine therapy for apnea of prematurity. N Engl J Med 357:1893–1902

    Article  CAS  Google Scholar 

  • Schmidt B, Roberts RS, Anderson PJ, Caffeine for Apnea of Prematurity (CAP) Trial Group et al (2017) Academic performance, motor function, and behavior 11 years after neonatal caffeine citrate Therapy for apnea of prematurity: an 11-year follow-up of the CAP randomized clinical trial. JAMA Pediatr 171(6):564–572

    Article  Google Scholar 

  • Shi Z, Ma L, Luo K et al (2017) Chorioamnionitis in the development of cerebral palsy: a meta-analysis and systematic review. Pediatrics 139(6):e20163781

    Article  Google Scholar 

  • Skidmore MD, Rivers A, Hack M (1990) Increased risk of cerebral palsy among very low – birthweight infants with chronic lung disease. Dev Med Child Neurol 32:325–332

    Article  CAS  Google Scholar 

  • Stoll BJ, Hansen NI, Bell EF et al (2015) Trends in care practices, morbidity and mortality of extremely preterm neonates, 1993–2012. JAMA 314(10):1039–1051

    Article  CAS  Google Scholar 

  • Tin W, Wiswell TE (2009) Drug therapies in bronchopulmonary dysplasia: debunking the myths. Semin Fetal Neonatal Med 14(6):383–390

    Article  Google Scholar 

  • Tonson la Tour A, Spadola L, Sayegh Y et al (2013) Chest CT in bronchopulmonary dysplasia: clinical and radiological correlations. Pediatr Pulmonol 48:693–698

    Article  Google Scholar 

  • Van Marter LJ, Kuban KCK, Allred E et al (2011) Does bronchopulmonary dysplasia contribute to the occurrence of cerebral palsy among infants born before 28 weeks of gestation? Arch Dis Child Fetal Neonatal Ed 96:20–29

    Article  Google Scholar 

  • Yeh TF, Chen CM, Wu SY et al (2016) Intratracheal administration of budesonide/surfactant to prevent bronchopulmonary dysplasia. Am J Respir Crit Care Med 193:86–95

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Pulmonary and Respiratory Diseases, Boston Children’s Hospital, Boston, MA, USA

    Frances Flanagan

  2. Department of Pediatrics, Division of Pulmonary Medicine, Children’s Hospital of Philadelphia, Philadelphia, PA, USA

    Anita Bhandari

Authors
  1. Frances Flanagan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anita Bhandari
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anita Bhandari .

Editor information

Editors and Affiliations

  1. Alfred I. duPont Institute, Wilmington, DE, USA

    Freeman Miller

  2. Cerebral Palsy Program, AI DuPont Hospital for Children , Wilmington, DE, USA

    Steven Bachrach

  3. AI DuPont Hospital for Children , Wilmington, DE, USA

    Nancy Lennon

  4. Drexel University, PHILADELPHIA, PA, USA

    Margaret O'Neil

Section Editor information

  1. Department of Pediatrics (Emeritus), Nemours/Alfred I. duPont Hospital for Children, Wilmington, DE, USA

    Steven J. Bachrach

  2. Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, PA, USA

    Steven J. Bachrach

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Flanagan, F., Bhandari, A. (2019). Bronchopulmonary Dysplasia and Cerebral Palsy. In: Miller, F., Bachrach, S., Lennon, N., O'Neil, M. (eds) Cerebral Palsy. Springer, Cham. https://doi.org/10.1007/978-3-319-50592-3_67-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-50592-3_67-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-50592-3

  • Online ISBN: 978-3-319-50592-3

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation